University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
University of Texas Southwestern Medical Center - William P. Clements, Jr., University Hospital, Dallas
University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
y 5 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07028853

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Texas Oncology, Dallas
Urology San Antonio, San Antonio

ReclutandoFase 2/3

Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Urology Austin, Lakeway
Urology San Antonio, San Antonio
Woodlands Cancer Institute American Oncology Partners, The Woodlands

ReclutandoFase 3

Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06855277

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

The Center for Cancer and Blood Disorders, Arlington
University of Texas Southwestern Medical Center, Dallas
Renovatio Clinical, Houston
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 22 sept 2026 · NCT07213674

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Texas Oncology - DFW (Sammons CC), Dallas
MD Anderson Cancer Center, Houston

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07114601

A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer

Mary Crowley Cancer Research, Dallas

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 22 sept 2026 · NCT07570979

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Research Site, Austin
Research Site, Austin
Research Site, Houston
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 18 sept 2026 · NCT06952803

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

MD Anderson Cancer Center, Houston

ReclutandoFase 1/2

Edades de 18 en adelante · Hombres · Actualizado el 18 sept 2026 · NCT06085729

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT05011383

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

Parkland Health & Hospital System ( Site 0069), Dallas
UT Southwestern Medical Center ( Site 0039), Dallas
University of Texas-MD Anderson Cancer Center ( Site 0055), Houston

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT06925737

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

University of Texas MD Anderson Cancer Center, Houston
Next Oncology - Dallas, Irving

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 15 sept 2026 · NCT07493512

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

New Experimental Therapeutics - NEXT Oncology, Austin
Texas Oncology, Bedford
UT Southwest Simmons Cancer Center, Dallas
y 2 más

ReclutandoFase 1/2

Edades de 12 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT04585750

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

Urology Partners of North Texas (UPNT), Arlington

Reclutando

Edades de 18 en adelante · Hombres · Actualizado el 14 sept 2026 · NCT06511141

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

Urology Austin, PLLC - Research Department, Austin
Urology Clinics of North Texas, Dallas
University of Texas Southwestern Medical Center, Dallas
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

MD Anderson in The Woodlands, Conroe
Brooke Army Medical Center, Fort Sam Houston
UT MD Anderson Cancer Center, Houston
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 10 sept 2026 · NCT05946213

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

Investigational Site Number: 401, Houston

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 10 sept 2026 · NCT05997615

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

UT MD Anderson, Houston
NEXT Oncology, San Antonio

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06440005

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

SCRI Oncology Partners, Nashville

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 8 sept 2026 · NCT05800665

Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence

Urology Austin, Austin

ReclutandoFase 4

Edades de 18 en adelante · Hombres · Actualizado el 8 sept 2026 · NCT07569926

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Texas MD Anderson Cancer Center, Houston
South Texas Accelerated Research Therapeutics (START), San Antonio

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06465069

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

SCRI at Mary Crowley, Dallas

ReclutandoFase 1

Edades de 18 en adelante · Hombres · Actualizado el 3 sept 2026 · NCT07545811

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Urology Clinics Of North Texas, Dallas
Urology Partners of North Texas (UPNT), Fort Worth
Houston Metro Urology (HMU), Houston

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 3 sept 2026 · NCT07723248

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

The Don and Sybil Harrington Cancer Center, Amarillo
UT MD Anderson Cancer Center, Houston
Audie L Murphy VA Hospital, San Antonio

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Covenant Medical Center-Lakeside, Lubbock

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 2 sept 2026 · NCT07200830

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
y 1 más

ReclutandoFase 3

Edades de 18 en adelante · Hombres · Actualizado el 2 sept 2026 · NCT06931340

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Parkland Memorial Hospital, Dallas
UT Southwestern Simmons Cancer Center - RedBird, Dallas
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
y 2 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06632977

Prostate Active Surveillance Study

University of Texas Health Science Center, San Antonio, San Antonio

ReclutandoEstudio observacional

Edades de 21 en adelante · Hombres · Actualizado el 2 sept 2026 · NCT00756665

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

University of Texas Southwestern Medical Center, Dallas

ReclutandoFase 2

Edades de 18 en adelante · Hombres · Actualizado el 31 ago 2026 · NCT05726292

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

Research Site, Houston

ReclutandoFase 1/2

Edades de 18 a 99 · Hombres · Actualizado el 27 ago 2026 · NCT07590934

De ClinicalTrials.gov, datos obtenidos el 29 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.